Cera's CEO, Dr. Ben Maruthappu, emphasized the company's profitability and expansion into various home healthcare services, including nursing, physiotherapy, and mental health. The company has raised over $407 million to date and aims to alleviate pressure on the NHS by providing comprehensive home healthcare. Cera's competitors in the UK include Home Instead and Bluebird Care, while in the US, similar companies are Signify Health and Honor. Cera is keen to differentiate itself from failed healthcare startups like Babylon Health by leveraging its extensive data set and AI capabilities to deliver exceptional care.
Key takeaways:
- Cera, a UK-based in-home healthcare provider, raised $150 million in a debt and equity round to scale its AI-driven platform.
- The company claims its AI technology can predict over 80% of falls and 83% of hospitalizations a week before they happen, significantly reducing incidents and hospitalizations.
- Cera is the UK's largest non-NHS healthcare provider, covering about 30 million people with 10,000 carers and nurses, and works with over 150 local governments and two-thirds of NHS Integrated Care Systems.
- An independent analysis found Cera's AI-led home healthcare model saves the UK healthcare system £1 million a day.